Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Dr. Reddy's bringing coronavirus vaccine to India by 2020-end
  • India

    Dr. Reddy's bringing coronavirus vaccine to India by 2020-end

    Shubham Sharma
    Written by
    Shubham Sharma
    Twitter
    Last updated on Sep 16, 2020, 05:18 pm
    Dr. Reddy's bringing coronavirus vaccine to India by 2020-end
  • In a major development, Hyderabad-based pharma company Dr. Reddy's Laboratories has partnered with the Russian Direct Investment Fund (RDIF) to source their Sputnik V COVID-19 vaccine for India.

    The company will conduct a clinical trial of the shot, which, if successful, could make the vaccine available for the public by the end of this year.

    Here is all you need to know about it.

  • In this article
    Deal inked for clinical trial and supply Both aspects remain subject to regulatory approvals Sputnik V vaccine could provide credible option against COVID-19 Sputnik V will help India fight COVID-19: RDIF CEO Sputnik V was approved prematurely in August Regardless, Russia has been moving ahead with production, distribution
  • Deal

    Deal inked for clinical trial and supply

    Deal inked for clinical trial and supply
  • As part of the deal, announced a few hours ago, Dr. Reddy's Laboratories will be conducting a Phase-3 human trial of Sputnik V in India.

    Along with the study, the organization will also be buying 100 million doses of the shot, which has been billed as the world's officially approved COVID-19 vaccine, for people in the country.

  • Approvals

    Both aspects remain subject to regulatory approvals

  • Both trial and supply aspects of the deal remain subject to approvals from the Central Drugs Standard Control Organization - which will be looking at the data of the vaccine pre and post India trial.

    To note, just last week, NITI Aayog member VK Paul had said that the Indian government is willing to facilitate a late-stage trial for Sputnik V.

  • Comment

    Sputnik V vaccine could provide credible option against COVID-19

    Sputnik V vaccine could provide credible option against COVID-19
  • Meanwhile, speaking on the deal, GV Prasad, co-chairman & MD of Dr. Reddy's Laboratories, said, "We will be conducting Phase-3 trials in India to ensure safety and efficacy for the Indian population and to meet the requirements of the Indian regulators."

    "Sputnik V vaccine could provide a credible option in our fight against COVID-19 in India," he added.

  • Quote

    Sputnik V will help India fight COVID-19: RDIF CEO

  • "India is amongst most severely impacted countries from COVID-19," RDIF CEO Kirill Dmitriev said in a statement, adding that "we believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against COVID-19."

  • Details

    Sputnik V was approved prematurely in August

    Sputnik V was approved prematurely in August
  • Developed by Gamaleya Research Institute of Epidemiology and Microbiology and backed by RDIF, Sputnik V was registered on August 11, with President Putin claiming that the shot forms a stable immunity and one of his daughters had already been inoculated.

    However, as the approval was given after just two-month-long trials and no public data, many raised alarms over the safety standards.

  • Progress

    Regardless, Russia has been moving ahead with production, distribution

    Regardless, Russia has been moving ahead with production, distribution
  • Despite the questions, Russia has been moving ahead with the internal production and distribution of Sputnik V.

    The company started production last month and has already released the first batch of the shot in civil circulation, following necessary quality tests in the laboratories of Roszdravnadzor [Russia's medical device regulator].

    The country had also expressed willingness to partner with India for scaling up the production.

  • Russia News
  • NITI Aayog
  • Central Drugs Standard Control Organization
  • VK Paul
  • COVID-19
  •  
Latest News
  • India and Pakistan agree to cease firing along LoC
    India and Pakistan agree to cease firing along LoC
    India
  • Government releases rules for social media, OTT platforms; details here
    Government releases rules for social media, OTT platforms; details here
    Science
  • YouTube launches supervised accounts with parental controls tailored for teenagers
    YouTube launches supervised accounts with parental controls tailored for teenagers
    Science
  • D/N Test: England bowled out for 81, India need 49-runs
    D/N Test: England bowled out for 81, India need 49-runs
    Sports
  • Mohanlal's 'Drishyam 2' is getting a Bollywood remake? Apparently yes!
    Mohanlal's 'Drishyam 2' is getting a Bollywood remake? Apparently yes!
    Entertainment
Related Timelines
  • Russia, AstraZeneca to test combination of COVID-19 shots
    Russia, AstraZeneca to test combination of COVID-19 shots
    World
  • COVID-19 vaccine: India to produce 300 million Sputnik V doses
    COVID-19 vaccine: India to produce 300 million Sputnik V doses
    Science
  • India's neighbors train experts for clinical trials of COVID-19 vaccine
    India's neighbors train experts for clinical trials of COVID-19 vaccine
    India
  • Putin orders Russian authorities to start mass COVID-19 vaccinations
    Putin orders Russian authorities to start mass COVID-19 vaccinations
    World
Trending Topics
ISRO Vaccine Farmers Protest
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Narendra Modi Facebook YouTube Hollywood News WhatsApp Bollywood News ISRO Rahul Gandhi Yoga
Honda Batman Football News BMW Vaccine Reliance Jio OPPO Amazon Food News, Healthy Recipes Royal Challengers Bangalore
Toyota Fashion Tips Farmers Protest Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics
Avengers Neha Kakkar Premier League Big Bang Theory
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021